5 Lab Services Billed Separately Instead of Bundled

Image Source: Pexels

If you’ve noticed a new, separate line item on your medical bill for a simple blood draw or “specimen collection,” you aren’t imagining things. As of January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) has finalized significant updates to the Clinical Laboratory Fee Schedule (CLFS) that are changing the way diagnostic tests are packaged. While labs and doctors used to “bundle” the cost of collecting a sample into the price of the test itself, new federal rules are encouraging—and in some cases requiring—the unbundling of these costs. This means that for millions of patients, a single trip to the lab is now resulting in multiple charges where there used to be just one.

1. Specimen Collection Fees (Codes 36415 & G0471)

The most visible shift in 2026 is the expansion of separately payable fees for specimen collection. According to the CY 2026 CLFS Annual Update, CMS has established distinct payment rates for specific collection methods, including routine venipuncture (code 36415) and collection from a single patient by a laboratory (code G0471). This unbundling allows clinics to bill for the “labor and supplies” of taking the sample separately from the laboratory’s fee for actually running the analysis. If you see a $5 to $15 charge for “Venipuncture” alongside your actual blood test, it is a direct result of this 2026 “specimen-first” billing model.

2. Professional vs. Technical Components

In 2026, more diagnostic tests are being split into two distinct billing parts: the Technical Component (TC) and the Professional Component (PC). Under the latest Physician Fee Schedule rules, the “technical” part covers the equipment and the lab tech’s time, while the “professional” part covers the physician’s time spent interpreting the results. While this was common for X-rays, it is now being applied to a wider range of high-complexity clinical lab tests. This ensures that the pathologist who reviews your results can bill for their expertise even if they work at a different facility than the lab that owns the testing machines.

3. Clinical Laboratory Travel Fees (Codes P9603 & P9604)

For homebound patients or those in nursing homes, the “travel cost” of getting a lab technician to the bedside is no longer a hidden operational expense. The 2026 update includes specific, annually updated travel codes (P9603 and P9604) that are billable only when a technician travels to perform a specimen collection. Previously, these costs were often absorbed by the lab or included in a broader “home health” bundle. Now, these are lab services billed separately, reflecting the increased price of fuel and specialized transport for medical personnel.

4. Advanced Diagnostic Laboratory Tests (ADLTs)

The 2026 rules have carved out a special category for high-tech “Advanced Diagnostic Laboratory Tests,” which often involve DNA sequencing or complex algorithms. Unlike routine panels, these tests are exempt from the 15% annual payment reduction caps applied to other lab services. Because ADLTs are priced based on actual market data rather than a government fee schedule, they are almost always billed as standalone services to ensure the manufacturer receives the full “Maximum Fair Price.” If you are undergoing genetic screening this year, expect the bill to be unbundled from your general wellness visit.

5. Separate “Reasonable Charge” Basis Services

While most lab work is paid via a set fee schedule, a specific group of tests has been moved to a “Reasonable Charge” basis for 2026. This includes certain specialized cytology and pap smear codes, where the payment is updated annually based on the Consumer Price Index (which saw a 1.9% increase for 2026). By billing these on a reasonable charge basis instead of a flat fee, CMS allows for regional price variations. For the patient, this means the “price” of these labs can fluctuate depending on which facility you use, making it harder to predict the final cost of a standard screening.

The New Anatomy of a Lab Bill

The unbundling of lab services is part of a broader federal effort to bring “site-neutrality” and transparency to healthcare billing. By breaking a single visit into separate charges for collection, travel, and analysis, the government can more accurately track where medical dollars are being spent. However, for the consumer, this requires a more careful reading of the “Explanation of Benefits” (EOB). Don’t be alarmed if you see multiple entries for a single blood draw; instead, check that each code corresponds to a service you actually received, and ensure your lab is using the latest 2026 “specimen collection” modifiers to avoid accidental overcharges.

Have you noticed extra “collection fees” or “travel surcharges” on your lab bills this year? Leave a comment below and let us know what your newest line-item charge was called—we’re tracking these 2026 billing shifts in real-time.